Inhibition of aldose reductase by flavonoids: possible attenuation of diabetic complications
- PMID: 3086893
Item in Clipboard
Inhibition of aldose reductase by flavonoids: possible attenuation of diabetic complications
Prog Clin Biol Res.
1986.
No abstract available
Similar articles
-
[Aldose-reductase inhibitors and cataract formation (author's transl)].Klin Monbl Augenheilkd. 1980 Apr;176(4):514-5. doi: 10.1055/s-2008-1057488. Klin Monbl Augenheilkd. 1980. PMID: 6775130 French.
-
Inhibition of lens aldose reductase by Labiatae flavonoids.Planta Med. 1986 Jun;(3):239-40. Planta Med. 1986. PMID: 3092256 No abstract available.
-
[Inhibition of aldose reductase from the rat lens by flavonoids].Yao Xue Xue Bao. 1986 Oct;21(10):721-4. Yao Xue Xue Bao. 1986. PMID: 3107341 Chinese. No abstract available.
-
Aldose reductase inhibitors and diabetic complications.Am J Med. 1987 Aug;83(2):298-306. doi: 10.1016/0002-9343(87)90702-9. Am J Med. 1987. PMID: 3113248 Review. No abstract available.
-
Potential use of aldose reductase inhibitors to prevent diabetic complications.Clin Pharm. 1990 Jun;9(6):446-57. Clin Pharm. 1990. PMID: 2114249 Review.
Cited by
-
Characterizing the cytoprotective activity of Sarracenia purpurea L., a medicinal plant that inhibits glucotoxicity in PC12 cells.BMC Complement Altern Med. 2012 Dec 5;12:245. doi: 10.1186/1472-6882-12-245. BMC Complement Altern Med. 2012. PMID: 23216659 Free PMC article.
-
Flavonol morin targets host ACE2, IMP-α, PARP-1 and viral proteins of SARS-CoV-2, SARS-CoV and MERS-CoV critical for infection and survival: a computational analysis.J Biomol Struct Dyn. 2022 Aug;40(12):5515-5546. doi: 10.1080/07391102.2021.1871863. Epub 2021 Feb 1. J Biomol Struct Dyn. 2022. PMID: 33526003 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Medical